# Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem

> **NCT00319982** · PHASE2,PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 39 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Diltiazem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00319982
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319982, "Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00319982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*